文献速递血栓与止血贫血与红细胞疾病

血红蛋白C特质与血红蛋白C病的血栓形成风险:一项系统综述

Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review.
PubMed 文献 · Br J Haematol · 2024-01-30

该系统综述纳入22项研究、782例血红蛋白C特质(HbAC,n=694)或血红蛋白C病(HbCC,n=88)个体,评估其血栓形成风险。多数研究为病例报告或病例系列;两项研究提示HbAC较野生型血红蛋白(HbAA)可能增加静脉血栓栓塞风险,全部患者OR 2.2(95%CI 0.9-5.5),妊娠个体RR 3.7(95%CI 0.9-16)。

要点

  • 22项研究共782例HbAC(n=694)或HbCC(n=88)个体,多数为病例报告或病例系列。
  • 两项研究提示HbAC较HbAA可能增加VTE风险:全部患者OR 2.2(95%CI 0.9-5.5),妊娠个体RR 3.7(95%CI 0.9-16)。
  • 综述认为HbC可能是血栓形成的易感危险因素,但需前瞻性队列研究明确。

核心结论

  • 本综述是迄今对HbC特质或疾病患者血栓形成最大规模的评估,结果提示HbC可能是血栓形成的易感危险因素。
  • 需要前瞻性队列研究来明确该人群的血栓形成风险。

研究设计与样本

  • 系统文献综述,共纳入22项研究,代表782例HbAC(n=694)或HbCC(n=88)个体。
  • 15项研究描述HbAC(n=685)或HbCC(n=79)患者静脉血栓栓塞(VTE)的有无。
  • 7项研究描述HbAC(n=9)或HbCC(n=9)患者的动脉血栓形成。
  • 多数(n=20)研究为病例报告或病例系列。

主要发现

  • 两项研究提示HbAC较HbAA可能增加VTE风险:全部患者OR 2.2(95%CI 0.9-5.5)。
  • 妊娠个体中HbAC较HbAA的VTE风险RR 3.7(95%CI 0.9-16)。
  • HbCC患者可表现为慢性溶血、血液黏度增高和流变学改变,理论上可能转化为血栓风险增加。

局限性

  • 多数(n=20)研究为病例报告或病例系列。
  • 需要前瞻性队列研究来明确该人群的血栓形成风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The thrombotic risk with haemoglobin C trait (HbAC) or haemoglobin C disease (HbCC) is unclear. However, individuals with HbCC have demonstrated chronic haemolysis, higher blood viscosity and altered rheology when compared to individuals with wild-type haemoglobin (HbAA). These physiological alterations may theoretically translate to increased risk of thrombosis; therefore, a systematic literature review was performed to investigate the possible association between HbAC and/or HbCC and thrombosis. Twenty-two studies met inclusion criteria representing 782 individuals with HbAC (n = 694) or HbCC (n = 88). Fifteen studies described the presence/absence of venous thromboembolism (VTE) in patients with HbAC (n = 685) or HbCC (n = 79), while seven studies described patients with HbAC (n = 9) or HbCC (n = 9) and arterial thrombosis. Most (n = 20) studies were case reports or case series; however, two studies suggested a potential increased VTE risk with HbAC compared to HbAA in (i) all patients (OR 2.2, 95% CI: 0.9-5.5) and in (ii) pregnant individuals (RR 3.7, 95% CI 0.9-16). This review is the largest assessment of patients with HbC trait or disease and thrombosis to date; despite its limitations, the findings suggest HbC may be a predisposing risk factor to thrombosis. Prospective cohort studies are warranted to definitively elucidate the risk of thrombosis in this population.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Jacobs JW, Sharma D, Stephens LD, et al. Thrombosis risk with haemoglobin C trait and haemoglobin C disease: A systematic review. Br J Haematol. 2024. PMID: 38291731. doi:10.1111/bjh.19313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。